ORPHAN Cures Act

Hozzl · 2024-12-19T09:06:06Z

Explore the details of House Bill 5539 ORPHAN Cures Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/19/2024, 9:06 AM

Summary of Bill HR 5539

The Bill 118 hr 5539, also known as the ORPHAN Cures Act, is a piece of legislation introduced in the US Congress with the aim of addressing the needs of individuals with rare diseases, also known as orphan diseases. The bill seeks to improve access to treatments and cures for these diseases by providing funding for research and development of orphan drugs.

Specifically, the ORPHAN Cures Act aims to streamline the drug approval process for orphan drugs, which are medications designed to treat rare diseases that affect a small number of individuals. The bill also seeks to incentivize pharmaceutical companies to develop orphan drugs by providing tax credits and other financial incentives.

Additionally, the ORPHAN Cures Act includes provisions to improve coordination between government agencies, healthcare providers, and patient advocacy groups in order to better support individuals with rare diseases. The bill also calls for increased funding for research into orphan diseases and for the establishment of a national registry to track the prevalence of these conditions. Overall, the ORPHAN Cures Act is a comprehensive piece of legislation aimed at improving access to treatments and cures for individuals with rare diseases. It seeks to address the unique challenges faced by individuals with orphan diseases and to promote innovation in the development of new therapies.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5539

Bill HR 5539 is currently in the status of Bill Introduced since September 18, 2023. Bill HR 5539 was introduced during Congress 118 and was introduced to the House on September 18, 2023. Bill HR 5539's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 5539

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5539

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5539

ORPHAN Cures ActORPHAN Cures ActOptimizing Research Progress Hope And New Cures ActTo amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.

Start holding our government accountable!